# Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/doxorubicin-and-paclitaxel-versus-doxorubicin-and-cyclophosphamide-as-first-line/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Laura Biganzoli,Tanja Čufer,P.F. Bruning,Robert E. Coleman,Luc Duchateau,A H Calvert,Teresa Gamucci,Chris Twelves,P. Fargeot,Ron Epelbaum,Caroline Lohrisch,M. Piccart |
| Citations | 220 |
| DOI | 10.1200/jco.2002.11.005 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2156836759 |
| PMID | 12118025 |
| Type | article |
| Year | 2002 |

## Paper authors

- [Caroline Lohrisch](https://scholariq.org/researchers/caroline-lohrisch/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Paper topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.